COMMENTARY

Low-Dose Aspirin: When Does the Benefit Outweigh the Risks?

Maurie Markman, MD

January 28, 2010

This feature requires the newest version of Flash. You can download it here.

Citation: Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152:1-9. Abstract

Cite this: Maurie Markman. Low-Dose Aspirin: When Does the Benefit Outweigh the Risks? - Medscape - Jan 28, 2010.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Low-Dose Aspirin: When Does the Benefit Outweigh the Risks?

Tables

Authors and Disclosures

Authors and Disclosures

Author(s)

Maurie Markman, MD

Comments

Email This

Feedback